Psychedelics 1

The resurgence of interest in psychedelic therapy has prompted both scientific and policy-related discussions about its use for treating psychiatric disorders, including addiction. This session explores the evolving role of psychedelics in both clinical and non-clinical settings. Topics include a review of psychedelic therapies for addiction, a study of state-level policy changes in the U.S. regarding psilocybin, and the implications for consumption and supply trends. Additionally, the session covers concerns about unregulated psychedelic practices, such as retreats in Europe, and how developments in clinical research are influencing these practices.